RT @pe_bartko: Grading Functional Mitral Regurgitation: Integrative Approach? Quantitative Assessment? -> Time for Integrated Quantificat…
RT @KagiyamaNobu: #JACC #一人抄読会 @ggoliasch 背景: 2次性MRの重症度は議論あり 方法: HFrEF423例 結果:MR定量とriskは関連した(図)。ここからEROA 20-29 or RegVol 30-44を中、以下を低、以上を高r…
#JACC #一人抄読会 @ggoliasch 背景: 2次性MRの重症度は議論あり 方法: HFrEF423例 結果:MR定量とriskは関連した(図)。ここからEROA 20-29 or RegVol 30-44を中、以下を低、以上を高riskとし、さらに中はRevFrac 50%以上なら高リスクとするとGLよりも精度よく死亡を予測した https://t.co/naDM9ou66H https://t.co/FjJP11AU2X
RT @JACCJournals: Is there a unifying solution to the secondary #cvMR guideline variance in thresholds? https://t.co/UFEhGXC7Xa #JACC @ggol…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @BartsEcho: Risk stratification of secondary MR according to RF, RV and ERO. New combined assessment of the unifying cutoffs for EROA,…
RT @pe_bartko: Grading Functional Mitral Regurgitation: Integrative Approach? Quantitative Assessment? -> Time for Integrated Quantificat…
RT @JACCJournals: Is there a unifying solution to the secondary #cvMR guideline variance in thresholds? https://t.co/UFEhGXC7Xa #JACC @ggol…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @JACCJournals: Is there a unifying solution to the secondary #cvMR guideline variance in thresholds? https://t.co/UFEhGXC7Xa #JACC @ggol…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
😨
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @PattiVassalloMd: Nice schematic of secondary MR. Always Optimize GDMT first. #MitralRegurgitation A Unifying Concept for the Quantita…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @JACCJournals: How can effective regurgitant orifice area be used to classify risk groups for those with secondary #cvMR to help unify t…
RT @JACCJournals: How can effective regurgitant orifice area be used to classify risk groups for those with secondary #cvMR to help unify t…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
Nice schematic of secondary MR. Always Optimize GDMT first. #MitralRegurgitation A Unifying Concept for the Quantitative Assessment of Secondary Mitral Regurgitation https://t.co/dLz3GVvToW https://t.co/0QYa6CFPNU
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
RT @Dr_DanMD: 1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes…
1⃣ Secondary/functional MR: due to primary LV dsyfx w/ nl leaflets/chords To ID severe disease w/ adverse long term outcomes use: ▪️EROA 3⃣0⃣ mm2, RVol 4⃣5⃣ml or more: high risk ▪️RF 5⃣0⃣% tiebreak intermediate risk pts @ggoliasch @JACCJournals📰 https:/
RT @JACCJournals: Is there a unifying solution to the secondary #cvMR guideline variance in thresholds? https://t.co/UFEhGXC7Xa #JACC @ggol…
RT @JACCJournals: Is there a unifying solution to the secondary #cvMR guideline variance in thresholds? https://t.co/UFEhGXC7Xa #JACC @ggol…
RT @JACCJournals: Is there a unifying solution to the secondary #cvMR guideline variance in thresholds? https://t.co/UFEhGXC7Xa #JACC @ggol…
RT @JACCJournals: Is there a unifying solution to the secondary #cvMR guideline variance in thresholds? https://t.co/UFEhGXC7Xa #JACC @ggol…
RT @isabel_azevedo_: A Unifying Concept for the Quantitative Assessment of Secondary Mitral Regurgitation https://t.co/sPtnef2eTy https://…
RT @JACCJournals: Is there a unifying solution to the secondary #cvMR guideline variance in thresholds? https://t.co/UFEhGXC7Xa #JACC @ggol…
RT @JACCJournals: Is there a unifying solution to the secondary #cvMR guideline variance in thresholds? https://t.co/UFEhGXC7Xa #JACC @ggol…
RT @JACCJournals: Is there a unifying solution to the secondary #cvMR guideline variance in thresholds? https://t.co/UFEhGXC7Xa #JACC @ggol…
RT @JACCJournals: Is there a unifying solution to the secondary #cvMR guideline variance in thresholds? https://t.co/UFEhGXC7Xa #JACC @ggol…
An eloquent #stratification of secondary #mitral regurgitation thresholds. @JACCJournals #valvulardisease #cardiology @ELS_Cardiology
RT @JACCJournals: Is there a unifying solution to the secondary #cvMR guideline variance in thresholds? https://t.co/UFEhGXC7Xa #JACC @ggol…
RT @isabel_azevedo_: A Unifying Concept for the Quantitative Assessment of Secondary Mitral Regurgitation https://t.co/sPtnef2eTy https://…
RT @JACCJournals: Is there a unifying solution to the secondary #cvMR guideline variance in thresholds? https://t.co/UFEhGXC7Xa #JACC @ggol…
RT @isabel_azevedo_: A Unifying Concept for the Quantitative Assessment of Secondary Mitral Regurgitation https://t.co/sPtnef2eTy https://…
RT @JACCJournals: Is there a unifying solution to the secondary #cvMR guideline variance in thresholds? https://t.co/UFEhGXC7Xa #JACC @ggol…
RT @JACCJournals: Is there a unifying solution to the secondary #cvMR guideline variance in thresholds? https://t.co/UFEhGXC7Xa #JACC @ggol…
RT @isabel_azevedo_: A Unifying Concept for the Quantitative Assessment of Secondary Mitral Regurgitation https://t.co/sPtnef2eTy https://…
RT @JACCJournals: Is there a unifying solution to the secondary #cvMR guideline variance in thresholds? https://t.co/UFEhGXC7Xa #JACC @ggol…
RT @JACCJournals: Is there a unifying solution to the secondary #cvMR guideline variance in thresholds? https://t.co/UFEhGXC7Xa #JACC @ggol…
RT @JACCJournals: Is there a unifying solution to the secondary #cvMR guideline variance in thresholds? https://t.co/UFEhGXC7Xa #JACC @ggol…
RT @JACCJournals: How can effective regurgitant orifice area be used to classify risk groups for those with secondary #cvMR to help unify t…
RT @JACCJournals: Is there a unifying solution to the secondary #cvMR guideline variance in thresholds? https://t.co/UFEhGXC7Xa #JACC @ggol…